PL3615565T3 - Tcr i peptydy - Google Patents

Tcr i peptydy

Info

Publication number
PL3615565T3
PL3615565T3 PL18722426.6T PL18722426T PL3615565T3 PL 3615565 T3 PL3615565 T3 PL 3615565T3 PL 18722426 T PL18722426 T PL 18722426T PL 3615565 T3 PL3615565 T3 PL 3615565T3
Authority
PL
Poland
Prior art keywords
tcr
peptides
Prior art date
Application number
PL18722426.6T
Other languages
English (en)
Inventor
Maria Chiara Bonini
Eliana RUGGIERO
Zulma Irene MAGNANI
Luca Aldo Edoardo VAGO
Attilio Bondanza
Fabio CICERI
Original Assignee
Ospedale San Raffaele S.R.L.
Fondazione Centro San Raffaele
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ospedale San Raffaele S.R.L., Fondazione Centro San Raffaele filed Critical Ospedale San Raffaele S.R.L.
Publication of PL3615565T3 publication Critical patent/PL3615565T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/32—T-cell receptors [TCR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4242—Transcription factors, e.g. SOX or c-MYC
    • A61K40/4243—Wilms tumor 1 [WT1]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL18722426.6T 2017-04-24 2018-04-24 Tcr i peptydy PL3615565T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762489226P 2017-04-24 2017-04-24
PCT/EP2018/060477 WO2018197492A1 (en) 2017-04-24 2018-04-24 Tcr and peptides

Publications (1)

Publication Number Publication Date
PL3615565T3 true PL3615565T3 (pl) 2025-08-18

Family

ID=62116393

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18722426.6T PL3615565T3 (pl) 2017-04-24 2018-04-24 Tcr i peptydy

Country Status (20)

Country Link
US (3) US11597755B2 (pl)
EP (2) EP3615565B1 (pl)
JP (3) JP7328211B2 (pl)
KR (2) KR20250033330A (pl)
CN (1) CN110785432B (pl)
AU (2) AU2018259029B2 (pl)
BR (1) BR112019022321A2 (pl)
CA (1) CA3060343A1 (pl)
EA (1) EA201992536A1 (pl)
ES (1) ES3027565T3 (pl)
FI (1) FI3615565T3 (pl)
IL (2) IL270084B1 (pl)
MX (1) MX2023012065A (pl)
MY (1) MY199241A (pl)
PH (1) PH12019502400A1 (pl)
PL (1) PL3615565T3 (pl)
SA (1) SA519410362B1 (pl)
SG (1) SG11201909864TA (pl)
TW (1) TWI835730B (pl)
WO (1) WO2018197492A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9422547B1 (en) 2015-06-09 2016-08-23 Gigagen, Inc. Recombinant fusion proteins and libraries from immune cell repertoires
US11597755B2 (en) * 2017-04-24 2023-03-07 Ospedale San Raffaele S.R.L. TCR and peptides
GB201803178D0 (en) 2018-02-27 2018-04-11 Univ Oslo Hf Specific binding molecules for htert
CN109679917B (zh) * 2018-09-30 2020-09-25 北京鼎成肽源生物技术有限公司 一种lrfft2细胞
GB201817821D0 (en) * 2018-10-31 2018-12-19 Ospedale San Raffaele Srl TCR and peptides
US12448430B2 (en) * 2019-03-11 2025-10-21 Fred Hutchinson Cancer Center High avidity WT1 T cell receptors and uses thereof
EP3941491A4 (en) 2019-03-21 2023-03-29 Gigamune, Inc. ENGINEERED CELLS EXPRESSING ANTIVIRAL T-CELL RECEPTORS AND METHODS OF USE
WO2020214957A1 (en) 2019-04-19 2020-10-22 Tcrcure Biopharma Corp. Anti-pd-1 antibodies and uses thereof
CA3146298A1 (en) * 2019-07-30 2021-02-04 University Health Network T cell receptors and methods of use thereof
WO2021155518A1 (en) * 2020-02-05 2021-08-12 Tcrcure Biopharma Corp Anti-hpv t cell receptors and engineered cells
CN113621070A (zh) * 2020-05-06 2021-11-09 华夏英泰（北京）生物技术有限公司 一种t细胞抗原受体、其多聚体复合物及其制备方法和应用
CN112279908B (zh) * 2020-10-23 2024-03-19 魏放 识别ebv抗原短肽的t细胞受体及其应用
CN112521484A (zh) * 2020-12-03 2021-03-19 佛山市第一人民医院（中山大学附属佛山医院） 结肠癌肿瘤特异tcr序列及其应用
WO2022216574A1 (en) * 2021-04-05 2022-10-13 Janssen Biotech, Inc. Calr and jak2 t-cell receptors
WO2023081655A1 (en) * 2021-11-02 2023-05-11 Fred Hutchinson Cancer Center T cell immunotherapy for hematologic malignancies having an sf3b1 mutation
WO2023091420A2 (en) * 2021-11-16 2023-05-25 TCR2 Therapeutics Inc. Compositions and methods for t cell engineering
WO2023148494A1 (en) * 2022-02-03 2023-08-10 University College Cardiff Consultants Limited Novel t-cell receptor
WO2023193800A1 (zh) * 2022-04-07 2023-10-12 恺兴生命科技(上海)有限公司 嵌合多肽及其应用
WO2024081915A1 (en) * 2022-10-13 2024-04-18 Ann And Robert H. Lurie Children's Hospital Of Chicago Capture agents for detection of kawasaki disease
WO2025032194A1 (en) * 2023-08-08 2025-02-13 Ospedale San Raffaele S.R.L. T-cell receptors
NL2036853B1 (en) * 2024-01-22 2025-08-01 Academisch Ziekenhuis Leiden Haematopoietic-restricted minor histocompatibility antigens and uses thereof
CN119529098B (zh) * 2025-01-22 2025-05-30 北京可瑞生物科技有限公司 对mage-a1具有特异性的结合分子和抗cd3的融合蛋白
CN120943929A (zh) * 2025-05-13 2025-11-14 北京立康生命科技有限公司 靶向afp肽的t细胞受体、其制备方法及伴随诊断试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9803351D0 (en) 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
US7655249B2 (en) 1998-09-30 2010-02-02 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
GB0009760D0 (en) 2000-04-19 2000-06-07 Oxford Biomedica Ltd Method
GB0328363D0 (en) * 2003-12-06 2004-01-14 Imp College Innovations Ltd Therapeutically useful molecules
WO2014018863A1 (en) * 2012-07-27 2014-01-30 The Board Of Trustees Of The University Of Illinois Engineering t-cell receptors
JP6250288B2 (ja) * 2013-01-30 2017-12-20 株式会社医学生物学研究所 Ｔ細胞レセプターおよびその利用
EP3071594A4 (en) * 2013-11-22 2017-05-03 The Board of Trustees of the University of Illionis Engineered high-affinity human t cell receptors
JP6712261B2 (ja) 2014-08-04 2020-06-24 フレッド ハッチンソン キャンサー リサーチ センター Ｗｔ−１に特異的なｔ細胞免疫治療
WO2016161273A1 (en) * 2015-04-01 2016-10-06 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
US11597755B2 (en) * 2017-04-24 2023-03-07 Ospedale San Raffaele S.R.L. TCR and peptides

Also Published As

Publication number Publication date
WO2018197492A1 (en) 2018-11-01
TWI835730B (zh) 2024-03-21
EP3615565B1 (en) 2025-03-26
AU2018259029A1 (en) 2019-12-12
CN110785432A (zh) 2020-02-11
PH12019502400A1 (en) 2021-01-25
SG11201909864TA (en) 2019-11-28
US20240132569A1 (en) 2024-04-25
MY199241A (en) 2023-10-22
US20200123220A1 (en) 2020-04-23
IL323966A (en) 2025-12-01
TW201900675A (zh) 2019-01-01
AU2024203874A1 (en) 2024-08-29
ES3027565T3 (en) 2025-06-16
SA519410362B1 (ar) 2024-01-18
JP2023145687A (ja) 2023-10-11
IL270084A (en) 2019-12-31
KR102777396B1 (ko) 2025-03-06
BR112019022321A2 (pt) 2020-05-26
EP4585681A2 (en) 2025-07-16
KR20200020681A (ko) 2020-02-26
EP3615565A1 (en) 2020-03-04
KR20250033330A (ko) 2025-03-07
JP2025072432A (ja) 2025-05-09
CN110785432B (zh) 2024-12-27
US11597755B2 (en) 2023-03-07
AU2018259029B2 (en) 2024-03-07
CA3060343A1 (en) 2018-11-01
FI3615565T3 (fi) 2025-05-21
IL270084B1 (en) 2025-11-01
JP7328211B2 (ja) 2023-08-16
JP2020517308A (ja) 2020-06-18
US20250188145A1 (en) 2025-06-12
MX2023012065A (es) 2023-10-23
EA201992536A1 (ru) 2020-03-05

Similar Documents

Publication Publication Date Title
PL3615565T3 (pl) Tcr i peptydy
IL301053B2 (en) Variants of hsd17b13 and their uses
IL273327A (en) Chimeric polypeptides and their uses
IL275298A (en) Mitochondria-targeted peptides
GB201817821D0 (en) TCR and peptides
IL280808A (en) OX40-binding polypeptides and their uses
IL265834A (en) hla-restricted vgll1 peptides and their use
SG11202006669RA (en) Peptides and uses thereof
IL258863A (en) Integrin-binding peptides and their use
GB201707248D0 (en) Modified complement proteins and uses thereof
SG11201705759SA (en) Cytotoxic hexim1 peptides and uses thereof
IL269836B (en) Converted N-arylethyl-2-aminoquinoline-4-carboxamides and their use
GB201819200D0 (en) Polypeptide and uses thereof
ZA201901942B (en) Nnif and nnif-related peptides and related methods
ZA201904386B (en) S-arrestin peptides and therapeutic uses thereof
IL275211A (en) Fast and flexible segment chains - division
PT3438118T (pt) Derivado de peptídeo e utilização deste
HUP1700012A2 (en) Novel proteins and use thereof
EP3325499A4 (en) Novel peptide and use thereof
SG11201610918RA (en) Peptides and uses thereof
IL269843B (en) Converted N-arylethyl-2-arylquinoline-4-carboxamides and their use
HK40025436A (en) Tcr and peptides
GB201712268D0 (en) Polypeptides and uses thereof
GB201712266D0 (en) polypeptides and uses thereof
GB201812328D0 (en) Polypeptides and uses thereof